Do you have the same question? Follow this Question
Mar 20, 2025 - 01:53 PM
We’ve provided several answers to questions related to Invega Sustenna Injection (Paliperidone Palmitate) , see some other helpful Q&A related to this product.
Question: What precautions should be taken before starting Invega Sustenna?
Answer: Before starting Invega Sustenna, inform your doctor about any kidney or liver problems, history of seizures, heart problems, diabetes, or other chronic conditions. This ensures the medication is safe and suitable for the patient's health status.
Question: What is the DrugBank ID for Invega Sustenna?
Answer: The DrugBank ID for Invega Sustenna is DB01267. DrugBank provides comprehensive information about drugs, including their chemical, pharmacological, and pharmaceutical data.
Question: What is the elimination half-life of Invega Sustenna?
Answer: The elimination half-life of Invega Sustenna is 23 hours. This is the time it takes for half of the drug to be eliminated from the body, which affects dosing schedules and the duration of the drug's effects.
View all Invega Sustenna Injection (Paliperidone Palmitate) Questions & Answers
